Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients

Coronavirus disease 2019 (COVID-19) caused a progress in research to find a solution to this pandemic. Also, various advances in pharmacotherapy against COVID-19 have emerged. Regarding antiviral therapy, casirivimab and imdevimab are antibodies combination against COVID-19. Standard antiviral thera...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Hegazy Sahar K., Tharwat Samar, Hassan Ahmed H.
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: De Gruyter 2023-08-01
Ráidu:Open Medicine
Fáttát:
Liŋkkat:https://doi.org/10.1515/med-2023-0768